These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 25380928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Fatty acid profile in phospholipids fraction with regard to blood pressure control in the kidney transplant patients].
    Wilusz M, Cieniawski D, Ignacak E, Bugajska J, Berska J, Bętkowska-Prokop A, Kużniewski M, Sułowicz W, Sztefko K.
    Przegl Lek; 2016; 73(9):621-6. PubMed ID: 29688661
    [Abstract] [Full Text] [Related]

  • 4. Role of dendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients.
    John K, Dieterlen MT, Tarnok A, Garbade J, Bittner HB, Mohr FW, Barten MJ.
    Cytometry B Clin Cytom; 2014 Sep; 86(5):362-7. PubMed ID: 24668729
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
    Fuchs U, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Transpl Immunol; 2014 Aug; 31(2):87-91. PubMed ID: 24932812
    [Abstract] [Full Text] [Related]

  • 6. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.
    Castel MA, Farrero M, Vallejos I, Cardona M, Regueiro A, Pérez-Villa F.
    Transplant Proc; 2011 Aug; 43(6):2244-6. PubMed ID: 21839245
    [Abstract] [Full Text] [Related]

  • 7. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I.
    Transplantation; 2013 Feb 27; 95(4):629-34. PubMed ID: 23423270
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
    Rathi M, Rajkumar V, Rao N, Sharma A, Kumar S, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Sakhuja V.
    Transplant Proc; 2015 May 27; 47(4):1158-61. PubMed ID: 26036543
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma fatty acid profile in advanced cirrhosis: unsaturation deficit of lipid fractions.
    Cabré E, Periago JL, Abad-Lacruz A, González-Huix F, González J, Esteve-Comas M, Fernández-Bañares F, Planas R, Gil A, Sánchez-Medina F.
    Am J Gastroenterol; 1990 Dec 27; 85(12):1597-604. PubMed ID: 2252024
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct 27; 36(8):2384-5. PubMed ID: 15561256
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 17. Effects of different quantities of fat on serum and liver lipids, phospholipid class distribution and fatty acid composition in alcohol-treated rats.
    Ristić-Medić D, Ristić G, Tepsić V, Ristić GN.
    J Nutr Sci Vitaminol (Tokyo); 2003 Dec 27; 49(6):367-74. PubMed ID: 14974725
    [Abstract] [Full Text] [Related]

  • 18. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 27; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.
    Lee YJ, Kim B, Lee JE, Kim YG, Kim DJ, Kim SJ, Joh JW, Oh HY, Huh W.
    Transpl Int; 2010 Feb 27; 23(2):147-54. PubMed ID: 19744223
    [Abstract] [Full Text] [Related]

  • 20. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
    Fuchs U, Klein S, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Ann Transplant; 2014 Jun 23; 19():300-4. PubMed ID: 24953848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.